JANX Smart Money
Janux Therapeutics, Inc.
1W: -0.3%
1M: +2.4%
3M: +11.3%
YTD: +22.3%
1Y: -31.8%
3Y: +134.4%
5Y: -21.4%
$17.26
+0.57 (+3.42%)
After Hours: $17.23 (-0.04, -0.20%)
Weekly Expected Move ±6.3%
$15
$16
$17
$18
$19
Credit Risk of going bust: higher than 54% of companies Debt: 2.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.06 (down 99.6%), Janux Therapeutics, Inc. would be worth roughly what it owes.
Total debt $21.0M against a stock market value of $1.02B.
Distance to default 4.73 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $10.5M (short-term plus half of long-term), stock volatility 90.4%; Altman Z'' 16.27. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.06 (down 99.6%), Janux Therapeutics, Inc. would be worth roughly what it owes.
Total debt $21.0M against a stock market value of $1.02B.
Distance to default 4.73 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $10.5M (short-term plus half of long-term), stock volatility 90.4%; Altman Z'' 16.27. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026228
Institutions Holding
+8 vs prior
91.6%
Ownership
+10.68%
40
New
81
Increased
76
Reduced
31
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-31 | Campbell David Alan | officer: president and ceo | G-Gift | 123,840 | $— | $0 | Filing |
| 2026-06-11 | Shah Rajeev M. | director | A-Grant/Award | 5,500 | $— | $0 | Filing |
| 2026-06-11 | Kolchinsky Peter | director | A-Grant/Award | 5,500 | $— | $0 | Filing |
| 2026-06-11 | RA Capital Nexus Fund II, L.P. | director | A-Grant/Award | 5,500 | $— | $0 | Filing |
| 2026-06-11 | RA Capital Healthcare Fund LP | director | A-Grant/Award | 5,500 | $— | $0 | Filing |
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. | director | A-Grant/Award | 5,500 | $— | $0 | Filing |
| 2026-06-11 | Barrett Ronald W | director | A-Grant/Award | 5,500 | $— | $0 | Filing |
| 2026-06-11 | CAPPS VICKIE L | director | A-Grant/Award | 5,500 | $— | $0 | Filing |
| 2026-06-11 | DOBMEIER ERIC | director | A-Grant/Award | 5,500 | $— | $0 | Filing |
| 2026-06-11 | Hernday Natasha | director | A-Grant/Award | 5,500 | $— | $0 | Filing |
| 2026-06-11 | Kung Winston | director | A-Grant/Award | 5,500 | $— | $0 | Filing |
| 2026-06-11 | Simson Jake | director | A-Grant/Award | 5,500 | $— | $0 | Filing |
| 2026-06-02 | Doyle Janeen Noel | officer: chief corp. & bus. dev. ofcr | S-Sale | 4,059 | $14.03 | $57K | Filing |
| 2026-05-11 | Dobek Maria | officer: vice president, accounting | S-Sale | 2,038 | $14.17 | $29K | Filing |
| 2026-02-02 | Go William | officer: chief medical officer | A-Grant/Award | 44,000 | $— | $0 | Filing |
| 2026-01-02 | DiRaimondo Thomas | officer: chief scientific officer | A-Grant/Award | 31,400 | $— | $0 | Filing |
| 2026-01-02 | McIver Zachariah | officer: chief medical officer | A-Grant/Award | 29,000 | $— | $0 | Filing |
| 2026-01-02 | McIver Zachariah | officer: chief medical officer | S-Sale | 2,714 | $13.73 | $37K | Filing |
| 2026-01-02 | Winter Charles M. | officer: chief technical officer | A-Grant/Award | 28,600 | $— | $0 | Filing |
| 2026-01-02 | Winter Charles M. | officer: chief technical officer | S-Sale | 2,401 | $13.73 | $33K | Filing |
| 2026-01-02 | Meyer Andrew Hollman | officer: chief business officer | S-Sale | 1,879 | $13.73 | $26K | Filing |
| 2026-01-02 | Dobek Maria | officer: vice president, accounting | A-Grant/Award | 18,935 | $— | $0 | Filing |
| 2026-01-02 | Dobek Maria | officer: vice president, accounting | S-Sale | 1,462 | $13.73 | $20K | Filing |
| 2026-01-02 | Campbell David Alan | officer: president and ceo | A-Grant/Award | 96,600 | $— | $0 | Filing |
| 2026-01-02 | Campbell David Alan | officer: president and ceo | S-Sale | 8,072 | $13.73 | $111K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11,189,693 | $172M | — | 2026-06-30 | Filing |
| BlackRock, Inc. | 6,134,667 | $94M | +701,434 | 2026-06-30 | Filing |
| Prosight Management, LP | 3,804,481 | $58M | +254,481 | 2026-06-30 | Filing |
| STATE STREET CORP | 3,004,899 | $46M | +540,882 | 2026-06-30 | Filing |
| FMR LLC | 2,412,825 | $37M | -122,899 | 2026-06-30 | Filing |
| FEDERATED HERMES, INC. | 2,352,927 | $36M | +2,298,727 | 2026-06-30 | Filing |
| Point72 Asset Management, L.P. | 1,993,837 | $31M | +837,697 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,857,351 | $29M | +45,986 | 2026-06-30 | Filing |
| TCG Crossover Management, LLC | 1,789,617 | $27M | — | 2026-06-30 | Filing |
| Alyeska Investment Group, L.P. | 1,647,140 | $25M | +46,051 | 2026-06-30 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 1,507,360 | $23M | -90,290 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,330,710 | $20M | +40,454 | 2026-06-30 | Filing |
| TWO SIGMA INVESTMENTS, LP | 1,207,250 | $19M | +1,091,151 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,204,150 | $18M | +57,426 | 2026-06-30 | Filing |
| CITADEL ADVISORS LLC | 1,200,737 | $18M | +848,560 | 2026-06-30 | Filing |
| ALGERT GLOBAL LLC | 1,110,889 | $17M | +667,492 | 2026-06-30 | Filing |
| D. E. Shaw & Co., Inc. | 1,096,509 | $17M | +998,114 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 952,675 | $15M | +350,662 | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 910,460 | $14M | +108,814 | 2026-06-30 | Filing |
| MORGAN STANLEY | 836,966 | $13M | +133,026 | 2026-06-30 | Filing |